Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if PALI is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
34 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: neutral
Last trade: buy 9 days ago
Red flags: 4
124 filers reported a long position in PALI for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Soleus Capital Management, L.P. | $27.3M | 13.1M | New |
| B Group, Inc. | $23.9M | 11.4M | Unchanged |
| AMERIPRISE FINANCIAL INC | $23.2M | 11.1M | -3.7% |
| Jupiter Topco LLC | $22.4M | 10.7M | — |
| BlackRock, Inc. | $21.8M | 10.4M | +456.2% |
| Octagon Capital Advisors LP | $21.5M | 10.3M | Unchanged |
| PERCEPTIVE ADVISORS LLC | $17.6M | 8.4M | -5.6% |
| RA CAPITAL MANAGEMENT, L.P. | $14.9M | 7.1M | Unchanged |
| FRANKLIN RESOURCES INC | $12.1M | 5.8M | Unchanged |
| Point72 Asset Management, L.P. | $11M | 5.3M | +1,175.8% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.